Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Northwest Biotherapeutics (NWBO) Other Non Operating Income (2016 - 2025)

Historic Other Non Operating Income for Northwest Biotherapeutics (NWBO) over the last 15 years, with Q3 2025 value amounting to -$12.5 million.

  • Northwest Biotherapeutics' Other Non Operating Income fell 8341.64% to -$12.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$31.7 million, marking a year-over-year decrease of 44475.4%. This contributed to the annual value of -$17.3 million for FY2024, which is 14354.82% down from last year.
  • Latest data reveals that Northwest Biotherapeutics reported Other Non Operating Income of -$12.5 million as of Q3 2025, which was down 8341.64% from -$4.5 million recorded in Q2 2025.
  • In the past 5 years, Northwest Biotherapeutics' Other Non Operating Income ranged from a high of $145.8 million in Q4 2021 and a low of -$17.2 million during Q3 2022
  • Moreover, its 5-year median value for Other Non Operating Income was -$2.6 million (2024), whereas its average is $8.3 million.
  • The largest annual percentage gain for Northwest Biotherapeutics' Other Non Operating Income in the last 5 years was 37657.86% (2024), contrasted with its biggest fall of 73218.88% (2024).
  • Over the past 5 years, Northwest Biotherapeutics' Other Non Operating Income (Quarter) stood at $145.8 million in 2021, then tumbled by 106.94% to -$10.1 million in 2022, then skyrocketed by 111.51% to $1.2 million in 2023, then tumbled by 732.19% to -$7.4 million in 2024, then plummeted by 69.84% to -$12.5 million in 2025.
  • Its Other Non Operating Income was -$12.5 million in Q3 2025, compared to -$4.5 million in Q2 2025 and -$7.3 million in Q1 2025.